Dendritic cell-based immunotherapy. Curr. Top. Microbiol. Immunol. 2003, 276, 163-197.Berger TG, Schultz ES. Dendritic cell-based immunotherapy. Curr Top Microbiol Immunol 2003;276:163-97.Berger T.G., Schultz E.S. Dendritic cell-based immunotherapy. Curr. Top. Microbiol. Immunol. 2003; ...
Interestingly, intratumoral Flt3L not only mobilizes DCs into the TME but also achieves a systemic mobilization of DCs. Therefore, by increasing the DC numbers and localization to tumors and also providing a maturation stimulus, Flt3L may substantially improve anti-tumor T cell priming. The contribu...
Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminate tumor cells in metastatic hormone-refractory cancer. Overall, although many DC vaccines have been tested in the clinic and proven to be immuno...
Dendritic cell-based immunotherapy. Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminat... R Sabado,S Balan,N Bhardwaj - 《Cell Research》 被引量: 0发表: 2017年 Potential approaches for more...
G. Dendritic cell-based immunotherapy: state of the art and beyond. Clin. Cancer Res. 22, 1897–1906 (2016). Article CAS PubMed Google Scholar Garg, A. D., Coulie, P. G., Van den Eynde, B. J. & Agostinis, P. Integrating next-generation dendritic cell vaccines into the current...
These studies show that antigen-loaded dendritic cell vaccinations are safe and promising in the treatment of cancer. This review discusses the use of dendritic cells in immunotherapy and some of the clinical trials that have been conducted.
3 Dendritic cell immunotherapy Immunotherapy represents a rational therapeutic approach against ovarian cancer based on a body of evidence supporting a protective role of the immune system against this disease, and on the clinical success of immunotherapy in other malignancies. The most active area of ...
Dendritic cell-based immunotherapy of cancer: Current pitfalls and challenges Summary Natural Killer (NK) cells, a major actor of the innate immunity, play a central role in defences against viral infectious and tumor growth. NK cell... G Ferlazzo,L Moretta 被引量: 0发表: 2010年 ...
Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunol Immunother 46, 82–87 (1998). https://doi.org/10.1007/s002620050465 Download citation Issue DateApril 1998 DOIhttps://doi.org/10.1007/s002620050465 Share this article Anyone you share the following link with will be able ...
Dendritic cell-based immunotherapy for prostate cancer. Dendritic cells are unique in their ability to stimulate naive T cells. These investigators have developed a prostate cancer vaccine using autologous dendr... BA Tjoa,PA Lodge,ML Salgaller,... - 《Ca A Cancer Journal for Clinicians》 被引...